Some professionals stated that patients with a newly diagnosed eye disease, especially neovascular macular degeneration, often do not want to be referred to LVS right away, because they hope that the treatment (e.g. anti-VEGF injections) will improve their vision and therefore want to await the treatment effect. This evidence concerns the gene VEGFA and eye disorder.